No abstract available
MeSH terms
-
Antineoplastic Agents / administration & dosage*
-
Benzamides / administration & dosage*
-
Biomarkers, Tumor / analysis
-
Biomarkers, Tumor / genetics
-
Biopsy
-
Chemotherapy, Adjuvant
-
Gastrectomy*
-
Gastrointestinal Stromal Tumors / chemistry
-
Gastrointestinal Stromal Tumors / drug therapy*
-
Gastrointestinal Stromal Tumors / genetics
-
Gastrointestinal Stromal Tumors / pathology
-
Gastrointestinal Stromal Tumors / surgery*
-
Humans
-
Imatinib Mesylate
-
Immunohistochemistry
-
Male
-
Middle Aged
-
Mitotic Index
-
Multimodal Imaging
-
Mutation
-
Neoplasm Staging
-
Patient Selection
-
Piperazines / administration & dosage*
-
Positron-Emission Tomography
-
Precision Medicine
-
Predictive Value of Tests
-
Protein Kinase Inhibitors / administration & dosage*
-
Proto-Oncogene Proteins B-raf / genetics
-
Proto-Oncogene Proteins c-kit / analysis
-
Proto-Oncogene Proteins c-kit / genetics
-
Pyrimidines / administration & dosage*
-
Receptor, Platelet-Derived Growth Factor alpha / genetics
-
Risk Factors
-
Stomach Neoplasms / chemistry
-
Stomach Neoplasms / drug therapy*
-
Stomach Neoplasms / genetics
-
Stomach Neoplasms / pathology
-
Stomach Neoplasms / surgery*
-
Tomography, X-Ray Computed
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Benzamides
-
Biomarkers, Tumor
-
Piperazines
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Imatinib Mesylate
-
Proto-Oncogene Proteins c-kit
-
Receptor, Platelet-Derived Growth Factor alpha
-
BRAF protein, human
-
Proto-Oncogene Proteins B-raf